LINDSEY HIXON: Open Payments
NPI 1497308316 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$481 in 17 payments from 11 companies in 2025. Trend: 2023 $692 · 2024 $257 · 2025 $481
Food & beverage: $481
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $108 |
| Medtronic, Inc. | 1 | $72 |
| Boston Scientific Corporation | 2 | $61 |
| ABBVIE INC. | 3 | $61 |
| Smith+Nephew, Inc. | 1 | $47 |
| TOLMAR, INC. | 1 | $33 |
| Endo USA, Inc. | 1 | $27 |
| Medline Industries LP | 1 | $27 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Olympus America Inc. | 1 | $14 |
Products named: Xtandi, INTERSTIM, LUPRON DEPOT, STRAVIX, General - Therapies, JATENZO, AVEED, GEMTESA.
Industry payments across GA — which companies pay providers there.
